The protective effects of FGF21 on preventing cardiac hypertrophy have been evaluated in pathological animal models such as uremic cardiomyopathy rats 81, obesity-associated cardiomyopathy mice 82, and hypertension mice 51. Here, FGF21 is linked to cardiac hypertrophy.